HER2-Targeted Therapies for Metastatic Breast Cancer Watch our June 2024 MBC Impact Series, Metastatic HER2-Positive Breast Cancer. HER2 and metastatic breast cancer The HER2 protein is an important driver of cell growth and survival. A pathologist determines HER2 status by testing a sample of the metastatic tumor (from a biopsy of the metastases). Learn more […]| Susan G. Komen®
CDK4/6 Inhibitors for Metastatic Breast Cancer CDK4 and CDK6 are enzymes important in cell division. CDK4/6 inhibitors are drugs designed to interrupt the growth of cancer cells. CDK4/6 inhibitors are used in combination with hormone therapy to treat some hormone receptor-positive breast cancers. The CDK4/6 inhibitors FDA-approved for metastatic breast cancer treatment are: Drug name […]| Susan G. Komen®
Hormone Therapy for Metastatic Breast Cancer Watch Susan G. Komen®’s January 2024 MBC Impact Series, Metastatic Breast Cancer and Estrogen Receptor-Positive Breast Cancer. What is hormone therapy? Estrogen and progesterone are female hormones produced in the body. Some breast cancer cells need estrogen and/or progesterone to grow. When these hormones attach to special proteins called […]| Susan G. Komen®
Metastatic breast cancer (stage IV) is the most advanced stage of breast cancer. Learn about treatments for metastatic breast cancer.| Susan G. Komen®
In a small, rural town in southern Minnesota, Cyndi spent her days as a wife, mother and high school English teacher. In 2018, after she tried everything to mitigate persistent rib pain, she had an appointment that set her on a path she never anticipated.| Susan G. Komen®